The COVID-19 vaccine ramps up a nationwide inoculation program, as rising infection rates are putting an unprecedented strain on British hospitals.
By Danica Kirka, Associated Press
Britain has authorized an easy-to-handle coronavirus vaccine and decided to stretch out the time between doses to allow more people to get some level of protection faster as infections surge.
By Danica Kirka, Mike Corder, Associated Press
Two drugmakers say they have the go-ahead to resuming U.S. testing of their COVID-19 vaccine candidates. Both are in the final stage of testing before the companies can seek regulatory approval.
By Linda A. Johnson, Associated Press
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of…
By Arthur Allen, Liz Szabo, Kaiser Health News
By Pan Pylas, Associated Press
The vaccine being developed by Oxford and AstraZeneca is widely perceived to be one of the strongest contenders among the dozens of coronavirus vaccines in various stages of testing around the world.
By Lauren Neergaard
"This is not something to be alarmed about," Fuller said. Instead, it's reassuring that the company is pausing the study to figure out what's happening and carefully monitoring the health of study participants.
By PBS NewsHour
Pfizer made a $106 billion bid for the British drug maker AstraZeneca this week in a move that was potentially motivated by lower corporate tax rates overseas. The deal could also affect the development of new drugs. Hari Sreenivasan speaks…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.